SITE012-0195

SITE012 (BRA) › SITE012-0195

SITE012-0195

A Phase III, Randomized, Double-Blind Study of Torivumab Plus Chemotherapy Versus Placebo Plus Chemotherapy in Previously Untreated Advanced Non-Small Cell Lung Cancer · Phase III
SITE012 (BRA) · Dr. Kowalski
consented 2026-04-18

enrolled

AEs

2

Serious

1

Dropout signal

–

Adverse events

2

Grade 1 Hepatitis — outcome: RECOVERED/RESOLVED; onset 2023-01-21 (study day 81); relationship: RELATED

mild assessed

Grade 3 Asthenia — outcome: UNKNOWN; onset 2022-12-31 (study day 60); relationship: not assessed; serious criteria: hospitalization

severe serious assessed

Data queries

0

No data queries. Open queries would appear here for this patient.